Clinical trials

How to get involved in a clinical trial

‘Clinical trials are the ‘lifeblood’ of research in cancer medicine.

Without them there can be no progress,’ says neuro-oncologist Professor Roy Rampling. 'A clinical trial is a medical test or experiment on people including a new treatment or a new way of giving an existing treatment.

'Most often the treatment is a drug, but it could be a medical procedure or investigation. The treatment will have been tested on animals or in the lab with positive results, before getting to the clinical trial stage.'

Professor Rampling answers your questions:

How does a trial start?

A scientist develops a new idea either as a result of clinical experience or from laboratory experiments, for example: ‘If I give chemotherapy and radiotherapy together will patients have better outcomes than with radiotherapy alone?’

The scientist then writes a detailed plan for the trial (a protocol) and independent, experienced people have to like the idea (peer review) before it can be developed.

The idea also has to be approved by various other regulatory bodies, mainly to ensure the patients’ well-being is looked after. This process can take several years.

Who pays for a clinical trial and how much does it cost?

Clinical trials can cost millions of pounds. The scientists have to find money from government, or more usually, from specialist charities such as Brain Tumour UK and drug companies.

What is the aim of a clinical trial?

The overall aim is to find out if a new treatment or procedure is safe, helps patients feel better, has side effects or is better than existing treatments.

Clinical trials are often defined in four phases. Not all ideas have to complete all four but a new drug having to do so can take 10 – 12 years to come into general use.

  • Phase 1 trials ask: ‘Is the treatment safe, if so, how much treatment can we give? Does it have any harmful effects?’
  • Phase 2 trials ask: ‘Does the treatment do what we hoped - shrink tumours, stop them regrowing (for longer)?’
  • If the treatment works, Phase 3 trials ask: ‘Does it work better than the standard treatment?’
  • If a treatment reaches Phase 4, it has been shown to work and is being used to treat brain tumours. This phase looks at long-term side effects and benefits of a drug after it has been licensed for use.

How do I find out about clinical trials?

Ask the doctors looking after you or look on the internet for trials in the UK and abroad. You can search for a clinical trial close to you on the brain tumour hub.

What are the risks?

The new treatment may not be better and could even be worse than existing treatments. You may experience side effects that the doctors had not anticipated.

What are the benefits?

The treatment might work and you could be one of the first to receive it. You are likely to be monitored more closely than if you were not on the trial.

How am I chosen for a clinical trial?

Every trial has entry criteria or conditions for taking part to ensure you’re fit enough and to increase the chance of the trial being successful. Criteria might include: type and stage of cancer, age, health and other treatments. If you do not fit the criteria your doctor can’t commit you to the trial.

What happens next?

You will meet the trial doctor so that you can be given all the information and can ask questions. Your partner, carer or someone else can go with you for support.

If you want to go ahead, you will have to sign a statement to say you understand what it means to take part in the trial. The process is called giving informed consent.

What if I agree to enter the trial but then want to leave?

You can withdraw from a trial at any time without having to give a reason.

How long do I stay on the trial?

You will stay on the trial until one or more of these things happen:

  • the trial ends
  • the side effects patients are having approach the limit agreed in the protocol document
  • the treatment is clearly not working
  • the doctor running the trial thinks it is in your best interest to leave
  • you decide to leave

Will I be out of pocket?

No, patients have to be reimbursed for any out-of-pocket expenses they have as a result of taking part in the trial, eg. travel fees.  

Version 1.1 January 2012 - Review date: January 2015

 

Clinical trials often generate many questions. If you have further enquiries please contact us and we will be back in touch.